Venrock Healthcare Capital Partners II L.P. 13D/13G Filings for Provention Bio, Inc. (PRVB)

Venrock Healthcare Capital Partners II L.P. 13D and 13G filings for Provention Bio, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-14
4:08 pm
Sale		 2022-12-31 13G Provention Bio, Inc.
PRVB		 Venrock Healthcare Capital Partners II L.P. 1,118,653
1.300%		 -2,725,143decrease
(-70.90%)		 Filing
2021-06-07
4:30 pm
Purchase		 2021-05-26 13G Provention Bio, Inc.
PRVB		 Venrock Healthcare Capital Partners II L.P. 3,843,796
6.100%		 3,843,796increase
(New Position)		 Filing